Research on the correlation between the PTR and platelet antibody of the oatients suffering from HD

( views:733, downloads:0 )
Author:
LIU Chuan-yong(Maoming City People's Hospital, Guangdong 525000, China)
ZHANG Xiong(Maoming City People's Hospital, Guangdong 525000, China)
GU Mao-qun(Maoming City People's Hospital, Guangdong 525000, China)
()
()
Journal Title:
CHINA CLINICAL PRACTICAL MEDICINE
Issue:
Volume 04, Issue 12, 2010
DOI:
10.3760/cma.j.issn 1673-8799.2010.12.43
Key Word:
Simplified sensitized erythrocyte platelet serology assay;Platelet antibody;Platelet transfusion resistance;Hematological diseases

Abstract: Objective To explore the correlation between the apheresis platelet transfusion resistance (PTR) and platelet antibody of the patients suffering from hematological diseases (HD). Methods In the light of the corrected count increment(CCI), the effect of platelet transfusion among 207 cases patients who suffered from HD were observed, then the platelet antibody were detected by the use of SEPSA(simplified sensitized erythrocyte platelet serology assay) and counting the occurrence of PTR and positive rate of platelet antibody. The patients were divided into positive platelet antibody group and negative platelet antibody group. The effects of platelet transfusion, 1 hCCI values and 24 hCCI values in two groups were compared. Results The PTR rate was 43.0% and positive rate of platelet antibody was 37.2% The PTR rates in positive platelet antibody group and negative platelet antibody group were absolutely different, which had statistical significance, (P< 0. 01).The 1 hCCI and 24 hCCI values in the positive platelet antibody group was obviously lower than those in the negative platelet antibody group, which also had statistical significance, (P< 0. 01). Conclusion When the apheresis platelets transfusion is conducted on the HD patients, the platelet antibody detection and platelet typing for positive platelet antibody patients should be made, so as to effectively prevent the occurrence of immune platelet transfusion resistance.

  • [1]李岚.血小板抗体检测及其配型在临床上的应用.中国现代医学杂志,2003,13(9):81-82.
  • [2]范厚臻.血小板抗体检测的意义与方法学进展.中国全科医学杂志,2006,9(10):856-857.
  • [3]张之南,沈悌.血液病诊断及疗效标准.科学出版社,2008:106-121,157-162,172-175,217-227,232-234.
  • [4]尤建国.血小板输注无效及干预措施的研究进展.国际输血及血液学杂志,2006,29(6):499-502.
  • [5]胡丽华.临床输血检验.北京:中国医药科技出版社,2004:118-119,274-275.
  • [6]林岳兴.血小板抗体对血小板输注效果的影响研究.中国卫生检验杂志,2010,20(1):116-117.
  • [7]Benson K,Fields K,Hiemenz J,et al.The platelet refractory bone marrow transplant patient:prophylaxis and treatment of bleeding.Sem in Oncon,1993,20(5):102-106.
  • [8]卢焕兴,王芳,梁永生.血小板抗体对血小板输注的疗效观察.实验与检验医学杂志,2009,27(3):255-256.
  • [9]董伟群,郭萍,佟力.血液病患者血小板无效输注的免疫因素探讨.中国输血杂志,2009,22(4):304-305.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn